Physician profile
Dent Williams
NPI 1134173164
$841.73
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $145 · 2021: $248 · 2022: $167.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $351.97 | 2019-2022 | |
| Astellas Pharma US INC | $207.32 | 2019-2022 | |
| Therapeuticsmd, INC. | $44.66 | 2019 | |
| Amgen INC. | $44.38 | 2019 | |
| Mannkind Corporation | $42.37 | 2019-2020 | |
| Evofem Biosciences, INC. | $27.99 | 2021 | |
| Hologic Sales and Service, LLC | $24.99 | 2020 | |
| Mayne Pharma Commercial LLC | $21.39 | 2022 | |
| Scynexis, INC. | $14.83 | 2022 | |
| Avion Pharmaceuticals | $13.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.83 | 2021 | |
| Coopersurgical, INC. | $12.78 | 2020 | |
| Daiichi Sankyo INC. | $11.89 | 2021 | |
| Vivus LLC | $10.97 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dent Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.